NCT02667483View on ClinicalTrials.gov

Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 20, 2020

Study Completion Date

October 20, 2020

Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG

DS-5141b

DS-5141b, Subcutaneous injection

Trial Locations (2)

650-0017

Kobe University Hospital, Hyōgo

187-8551

National Center of Neurology and Psychiatry, Tokyo

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

Daiichi Sankyo Co., Ltd.

INDUSTRY